- Home
- FRPT vs ZLAB Comparison
FRPT vs ZLAB Comparison
Compare FRPT & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRPT
- ZLAB
- Stock Information
- Founded
- FRPT 2004
- ZLAB 2013
- Country
- FRPT United States
- ZLAB China
- Employees
- FRPT N/A
- ZLAB N/A
- Industry
- FRPT Packaged Foods
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- FRPT Consumer Staples
- ZLAB Health Care
- Exchange
- FRPT Nasdaq
- ZLAB Nasdaq
- Market Cap
- FRPT 2.4B
- ZLAB 2.2B
- IPO Year
- FRPT 2014
- ZLAB 2017
- Fundamental
- Price
- FRPT $55.52
- ZLAB $19.88
- Analyst Decision
- FRPT Buy
- ZLAB Buy
- Analyst Count
- FRPT 14
- ZLAB 6
- Target Price
- FRPT $77.00
- ZLAB $57.22
- AVG Volume (30 Days)
- FRPT 1.4M
- ZLAB 931.8K
- Earning Date
- FRPT 11-03-2025
- ZLAB 11-06-2025
- Dividend Yield
- FRPT N/A
- ZLAB N/A
- EPS Growth
- FRPT 169.38
- ZLAB N/A
- EPS
- FRPT 2.38
- ZLAB N/A
- Revenue
- FRPT $1,079,494,000.00
- ZLAB $441,629,000.00
- Revenue This Year
- FRPT $15.88
- ZLAB $40.71
- Revenue Next Year
- FRPT $11.59
- ZLAB $50.42
- P/E Ratio
- FRPT $23.41
- ZLAB N/A
- Revenue Growth
- FRPT 16.34
- ZLAB 24.14
- 52 Week Low
- FRPT $46.76
- ZLAB $19.51
- 52 Week High
- FRPT $164.07
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- FRPT 55.76
- ZLAB 18.64
- Support Level
- FRPT $51.80
- ZLAB $19.51
- Resistance Level
- FRPT $55.00
- ZLAB $20.29
- Average True Range (ATR)
- FRPT 2.21
- ZLAB 0.76
- MACD
- FRPT 0.01
- ZLAB 0.02
- Stochastic Oscillator
- FRPT 67.76
- ZLAB 7.44
About FRPT Freshpet Inc.
Freshpet produces and sells premium fresh pet food through its company-owned refrigerators placed in grocery, mass and club, pet specialty, and natural stores. Freshpet primarily targets dogs (96% of 2024 sales), with cats and treats comprising the rest of its sales. Geographically, the company's home US market, where all its food is produced, accounts for about 98% of sales, with exports to Canada, the United Kingdom, and other European countries accounting for the remaining balance.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.